
https://www.science.org/content/blog-post/lab-equipment-any-h-cube-troubleshooters-out-there
# Lab Equipment: Any H-Cube Troubleshooters Out There? (November 2009)

## 1. SUMMARY

This article is a technical troubleshooting post from Derek Lowe's "In the Pipeline" blog about problems with an H-Cube hydrogenation machine. The H-Cube, manufactured by Thalesnano, was an early commercial flow chemistry instrument designed to perform catalytic hydrogenation reactions safely and efficiently in laboratory settings. The author had been successfully using the instrument until experiencing a specific malfunction: when operating in "Full H2" mode, the system would fail when the hydrogen valve closed during the transition to "Running" status. The flow would stop, a burst of solvent would discharge, and then only hydrogen gas would flow without liquid uptake. The author had already attempted standard maintenance procedures including cleaning the metal frit, replacing the Teflon membrane, sonicating the check valve, and trying different catalyst cartridges, but the problem persisted. This was essentially a call for help from other H-Cube users who might have encountered similar issues, written to avoid expensive technical support fees.

## 2. HISTORY

Looking at developments after this 2009 article, several important trends emerged in flow chemistry and the pharmaceutical industry:

**Thalesnano and H-Cube Evolution**: Thalesnano continued developing flow chemistry systems, with the H-Cube remaining a notable product in their portfolio. The company expanded their offerings to include more sophisticated flow chemistry platforms. However, the broader adoption of flow chemistry in pharmaceutical R&D progressed more slowly than some early proponents expected.

**Flow Chemistry Adoption**: While flow chemistry gained traction in specific applications, particularly in academic research and some industrial processes, widespread adoption across pharmaceutical discovery labs remained moderate rather than revolutionary. The technology proved valuable for certain reaction types (hydrogenations, oxidations, hazardous reactions) but didn't eliminate traditional batch chemistry approaches as some early advocates predicted.

**Industry Trends**: The period following 2009 saw continued consolidation in pharmaceutical R&D and increased pressure on efficiency, which might have been expected to drive flow chemistry adoption. However, practical barriers including equipment costs, training requirements, and the need for specialized expertise likely limited rapid widespread deployment.

**Technical Community Response**: Blog-based scientific communities continued to serve as valuable troubleshooting resources, though dedicated technical support from manufacturers remained the primary solution for instrument problems.

## 3. PREDICTIONS

No explicit predictions about future developments were made in this troubleshooting-focused article. The piece was entirely focused on immediate technical problem-solving rather than forecasting broader trends in chemistry, biotechnology, or pharmaceutical R&D.

## 4. INTEREST

Rating: **3/10**

This article serves primarily as a technical troubleshooting request with limited broader significance for biotechnology or pharmaceutical industry trends. While it provides a snapshot of practical challenges in adopting new laboratory technologies in the late 2000s, it lacks substantive commentary on strategic, scientific, or commercial developments that would make it highly valuable for understanding major shifts in the biotech sector. The content is narrowly focused on equipment maintenance rather than addressing significant scientific, regulatory, or business developments.


----
_model_params = {'model': 'nex-agi/deepseek-v3.1-nex-n1:free', 'input': '20091110-lab-equipment-any-h-cube-troubleshooters-out-there.txt', 'reasoning': {'effort': 'high'}, 'text': {'verbosity': 'medium'}, 'prompt-template': 'prompt-template-2'}_